Core Laboratories N.V.CLBNYSE
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank51
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P51
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -6.88% |
| Q3 2025 | -42.23% |
| Q2 2025 | 120.98% |
| Q1 2025 | -67.69% |
| Q4 2024 | 57.40% |
| Q3 2024 | -23.61% |
| Q2 2024 | 210.05% |
| Q1 2024 | -71.54% |
| Q4 2023 | 9097.74% |
| Q3 2023 | -102.47% |
| Q2 2023 | 375.83% |
| Q1 2023 | -123.99% |
| Q4 2022 | 125.83% |
| Q3 2022 | 866.94% |
| Q2 2022 | -88.56% |
| Q1 2022 | -17.62% |
| Q4 2021 | -46.27% |
| Q3 2021 | -32.46% |
| Q2 2021 | 121.56% |
| Q1 2021 | 167.42% |
| Q4 2020 | -157.25% |
| Q3 2020 | -23.35% |
| Q2 2020 | 22.57% |
| Q1 2020 | 3.39% |
| Q4 2019 | -18.03% |
| Q3 2019 | 52.16% |
| Q2 2019 | -32.10% |
| Q1 2019 | -33.63% |
| Q4 2018 | 58.96% |
| Q3 2018 | -11.66% |
| Q2 2018 | 16.88% |
| Q1 2018 | -49.71% |
| Q4 2017 | 53.68% |
| Q3 2017 | 59.65% |
| Q2 2017 | -37.12% |
| Q1 2017 | 28.26% |
| Q4 2016 | -33.46% |
| Q3 2016 | 25.81% |
| Q2 2016 | -39.87% |
| Q1 2016 | -6.55% |